Recently, some reports have indicated that IL‐36α applies potential anticancer effects on several types of cancer, such as hepatocellular carcinoma (HCC) [12], colorectal cancer [13] and epithelial ovarian cancer (EOC) [14]. This evidence concerns the gene IL36A and cancer.